These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37878674)

  • 21. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
    Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis.
    Sakane F; Hoshino F; Ebina M; Sakai H; Takahashi D
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases.
    Baldanzi G; Malerba M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diacylglycerol kinase alpha regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes.
    Alonso R; Rodríguez MC; Pindado J; Merino E; Mérida I; Izquierdo M
    J Biol Chem; 2005 Aug; 280(31):28439-50. PubMed ID: 15870081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics.
    McCloud RL; Franks CE; Campbell ST; Purow BW; Harris TE; Hsu KL
    Biochemistry; 2018 Jan; 57(2):231-236. PubMed ID: 29155586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diacylglycerol kinase α regulates tubular recycling endosome biogenesis and major histocompatibility complex class I recycling.
    Xie S; Naslavsky N; Caplan S
    J Biol Chem; 2014 Nov; 289(46):31914-31926. PubMed ID: 25248744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of diacylglycerol kinase alpha in the attenuation of receptor signaling.
    Sanjuán MA; Jones DR; Izquierdo M; Mérida I
    J Cell Biol; 2001 Apr; 153(1):207-20. PubMed ID: 11285286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lck-dependent tyrosine phosphorylation of diacylglycerol kinase alpha regulates its membrane association in T cells.
    Merino E; Avila-Flores A; Shirai Y; Moraga I; Saito N; Mérida I
    J Immunol; 2008 May; 180(9):5805-15. PubMed ID: 18424699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta.
    Guo R; Wan CK; Carpenter JH; Mousallem T; Boustany RM; Kuan CT; Burks AW; Zhong XP
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11909-14. PubMed ID: 18689679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
    Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
    Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
    Isoyama S; Mori S; Sugiyama D; Kojima Y; Tada Y; Shitara K; Hinohara K; Dan S; Nishikawa H
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction.
    Velnati S; Centonze S; Rossino G; Purghè B; Antona A; Racca L; Mula S; Ruffo E; Malacarne V; Malerba M; Manfredi M; Graziani A; Baldanzi G
    Front Immunol; 2023; 14():1043603. PubMed ID: 37138877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.
    Friedman J; Moore EC; Zolkind P; Robbins Y; Clavijo PE; Sun L; Greene S; Morisada MV; Mydlarz WK; Schmitt N; Hodge JW; Schreiber H; Van Waes C; Uppaluri R; Allen C
    Clin Cancer Res; 2020 Feb; 26(3):679-689. PubMed ID: 31645352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
    Yoo KJ; Johannes K; González LE; Patel A; Shuptrine CW; Opheim Z; Lenz K; Campbell K; Nguyen TA; Miriyala J; Smith C; McGuire A; Tsai YH; Rangwala F; de Silva S; Schreiber TH; Fromm G
    J Immunol; 2022 Aug; 209(3):510-525. PubMed ID: 35817517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane morphology determines diacylglycerol kinase α substrate acyl chain specificity.
    Bozelli JC; Yune J; Takahashi D; Sakane F; Epand RM
    FASEB J; 2021 Jun; 35(6):e21602. PubMed ID: 33977628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy.
    Kumar A; Chamoto K; Chowdhury PS; Honjo T
    Elife; 2020 Mar; 9():. PubMed ID: 32122466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diacylglycerol kinase alpha activity promotes survival of CD4+ 8+ double positive cells during thymocyte development.
    Outram SV; Crompton T; Merida I; Varas A; Martinez-A C
    Immunology; 2002 Apr; 105(4):391-8. PubMed ID: 11985659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.
    Purow B
    Clin Cancer Res; 2015 Nov; 21(22):5008-12. PubMed ID: 26420856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.